The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: A systematic review and meta‐analysis

Published:2022-08-02 Issue:10 Volume:36 Page:3774-3791
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Guo Xiaochuan¹²^ORCID,Li Yuanyuan¹³,Wang Weizheng⁴,Wang Luyao¹,Hu Sihan¹³,Xiao Xiaolin¹²,Hu Caiyu¹,Dai Yao¹,Zhang Yiheng¹,Li Ziyu¹,Li Junlin²,Ma Xiao²^ORCID,Zeng Jinhao¹

Affiliation:

1. Hospital of Chengdu University of Traditional Chinese Medicine Chengdu China

2. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu China

3. School of Acupuncture and Tuina Chengdu University of Traditional Chinese Medicine Chengdu China

4. School of Clinical Medicine Tsinghua University Beijing China

Funder

Beijing Medical and Health Foundation

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7569

Reference88 articles.

1. Hepatoprotective influence of quercetin and ellagic acid on thioacetamide-induced hepatotoxicity in rats